The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Posner Christopher since 2020.
This trader's CIK number is 1748265.
At the time of last reporting, Posner Christopher was the PRESIDENT AND CEO of Cara Therapeutics, Inc.. (stock ticker symbol CARA).
Also see all insider trading activities at Cara Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | CARA | 0 | $0 | 955 | $4,524 | 0 | $0 |
2024 | CARA | 0 | $0 | 53,162 | $29,513 | 0 | $0 |
2023 | CARA | 0 | $0 | 22,150 | $142,462 | 0 | $0 |
2022 | CARA | 0 | $0 | 2,006 | $25,416 | 0 | $0 |
2021 | CARA | 0 | $0 | 2,304 | $30,044 | 0 | $0 |
2020 | CARA | 0 | $0 | 2,000 | $31,638 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-28 | CARA | Sale | 583 | 4.75 | 2,769 |
2025-02-04 | CARA | Sale | 372 | 4.72 | 1,755 |
2024-11-04 | CARA | Sale | 3,668 | .29 | 1,063 |
2024-08-01 | CARA | Sale | 4,149 | .35 | 1,452 |
2024-05-02 | CARA | Sale | 3,936 | .75 | 2,952 |
2024-02-29 | CARA | Sale | 5,834 | .89 | 5,192 |
2024-02-08 | CARA | Sale | 35,575 | .53 | 18,854 |
2023-11-02 | CARA | Sale | 3,796 | 1.22 | 4,631 |
2023-08-03 | CARA | Sale | 4,307 | 3.07 | 13,222 |
2023-05-05 | CARA | Sale | 3,869 | 4.40 | 17,023 |
2023-03-03 | CARA | Sale | 5,987 | 9.71 | 58,133 |
2023-02-02 | CARA | Sale | 4,191 | 11.80 | 49,453 |
2022-04-04 | CARA | Sale | 2,006 | 12.67 | 25,416 |
2021-06-07 | CARA | Sale | 2,304 | 13.04 | 30,044 |
2020-11-19 | CARA | Sale | 2,000 | 15.82 | 31,638 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Posner Christopher (PRESIDENT AND CEO of Cara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.